BOLT-DVT records complete or near-complete thrombus reduction in 98% of patients

Patrick Muck (Good Samaritan Hospital, Cincinnati, USA) speaks to Venous News at The VEINS 2026 (3–4 October, Las Vegas, USA) after presenting the primary results of the BOLT-DVT investigational device exemption (IDE) trial that evaluated the safety and effectiveness of computer-assisted vacuum thrombectomy (CAVT; Penumbra) as a first-line treatment for patients with acute iliofemoral deep vein thrombosis (DVT).